Our Business Fields
Intravenously Administered Drugs
Fresenius Kabi offers a broad range of intravenously administered generic drugs across a wide array of therapeutic categories: oncology drugs, anesthetics & analgesics, anti-infectives, critical care drugs. For the administration of these products, the company provides the related medical devices.
For infusion therapy, Fresenius Kabi offers products for fluid and blood volume replacement. Moreover, Fresenius Kabi’s product portfolio includes a broad range of infusion technologies as well as disposables for the delivery of medication for all pharmaceuticals administered via the vein.
Within clinical nutrition, Fresenius Kabi is one of the few companies worldwide to offer parenteral nutrition (administered intravenously) and enteral nutrition (administered as sip or tube feed via the gastrointestinal tract), as well as nutrition pumps and infusion disposables.
Both serve to help patients who cannot eat any, or sufficient, normal food. This is especially the case for patients in intensive care units, for patients who are seriously ill and with malnutrition. When the patient leaves the hospital the ambulatory services of Fresenius Kabi can care for the patient and provide them with the necessary products.
In the field of biosimilars, we focus on autoimmune diseases and oncology. In 2019, the first biosimilar product by Fresenius Kabi was launched.
We offer devices used to administer I.V. generic drugs, infusion therapies and clinical nutrition products.
Transfusion Medicine and Cell Therapies
Within transfusion medicines and cell therapies, Fresenius Kabi offers products for collection of blood components and extracorporeal therapies.